Subscribe to RSS
DOI: 10.1055/s-0039-1679939
A Novel Diagnostic and Prognostic Score for Abdominal Aortic Aneurysms Based on D-Dimer and a Comprehensive Analysis of Myeloid Cell Parameters
Funding This work was primarily supported by the Austrian Science Fund (SFB project F 5409-B21) as well as the Medical Scientific Fund of the Mayor of the City of Vienna (project 15012) and The Garfield Weston Foundation (for the Leeds Aneurysm Development Study). Marc Bailey is supported by the British Heart Foundation. The sponsors had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the article for publication.Publication History
27 October 2018
12 January 2019
Publication Date:
01 March 2019 (online)
Abstract
The pathogenesis of abdominal aortic aneurysm (AAA) involves a central component of chronic inflammation which is predominantly mediated by myeloid cells. We hypothesized that the local inflammatory activity may be reflected in systemic alterations of neutrophil and monocyte populations as well as in soluble factors of myeloid cell activation and recruitment. To establish their marker potential, neutrophil and monocyte sub-sets were measured by flow cytometry in peripheral blood samples of 41 AAA patients and 38 healthy controls matched for age, sex, body mass index and smoking habit. Comparably, circulating factors reflecting neutrophil and monocyte activation and recruitment were assayed in plasma. Significantly elevated levels of CD16+ monocytes, activated neutrophils and newly released neutrophils were recorded for AAA patients compared with controls. In line, the monocyte chemoattractant C-C chemokine ligand 2 and myeloperoxidase were significantly increased in patients' plasma. The diagnostic value was highest for myeloperoxidase, a mediator which is released by activated neutrophils as well as CD16+ monocytes. Multivariable regression models using myeloid activation markers and routine laboratory parameters identified myeloperoxidase and D-dimer as strong independent correlates of AAA. These two biomarkers were combined to yield a diagnostic score which was subsequently challenged for confounders and confirmed in a validation cohort matched for cardiovascular disease. Importantly, the score was also found suited to predict rapid disease progression. In conclusion, D-dimer and myeloperoxidase represent two sensitive biomarkers of AAA which reflect distinct hallmarks (thrombus formation and inflammation) of the pathomechanism and, when combined, may serve as diagnostic and prognostic AAA score warranting further evaluation.
-
References
- 1 Moll FL, Powell JT, Fraedrich G. , et al; European Society for Vascular Surgery. Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery. Eur J Vasc Endovasc Surg 2011; 41 (Suppl. 01) S1-S58
- 2 Takagi H, Manabe H, Kawai N, Goto S, Umemoto T. Plasma fibrinogen and D-dimer concentrations are associated with the presence of abdominal aortic aneurysm: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2009; 38 (03) 273-277
- 3 Sidloff DA, Stather PW, Choke E, Bown MJ, Sayers RD. A systematic review and meta-analysis of the association between markers of hemostasis and abdominal aortic aneurysm presence and size. J Vasc Surg 2014; 59 (02) 528-535
- 4 De Haro J, Acin F, Bleda S, Varela C, Medina FJ, Esparza L. Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels. J Vasc Surg 2012; 56 (01) 45-52
- 5 Lee AJ, Fowkes FG, Lowe GD, Rumley A. Haemostatic factors, atherosclerosis and risk of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 1996; 7 (07) 695-701
- 6 Vele E, Kurtcehajic A, Zerem E, Maskovic J, Alibegovic E, Hujdurovic A. Plasma D-dimer as a predictor of the progression of abdominal aortic aneurysm. J Thromb Haemost 2016; 14 (11) 2298-2303
- 7 Golledge J, Muller R, Clancy P, McCann M, Norman PE. Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. Eur Heart J 2011; 32 (03) 354-364
- 8 Vega de Ceniga M, Esteban M, Barba A, Estallo L, Blanco-Colio LM, Martin-Ventura JL. Assessment of biomarkers and predictive model for short-term prospective abdominal aortic aneurysm growth-a pilot study. Ann Vasc Surg 2014; 28 (07) 1642-1648
- 9 Hellenthal FAMVI, Geenen ILA, Teijink JAW, Heeneman S, Schurink GW. Histological features of human abdominal aortic aneurysm are not related to clinical characteristics. Cardiovasc Pathol 2009; 18 (05) 286-293
- 10 Houard X, Touat Z, Ollivier V. , et al. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 2009; 82 (03) 532-541
- 11 Qin Y, Cao X, Yang Y, Shi GP. Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms. Future Cardiol 2013; 9 (01) 89-103
- 12 Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M. , et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 2012; 220 (02) 552-556
- 13 Juvonen J, Surcel HM, Satta J. , et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997; 17 (11) 2843-2847
- 14 Ziegler-Heitbrock L, Ancuta P, Crowe S. , et al. Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116 (16) e74-e80
- 15 Patel AA, Zhang Y, Fullerton JN. , et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med 2017; 214 (07) 1913-1923
- 16 Wong KL, Tai JJ, Wong WC. , et al. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011; 118 (05) e16-e31
- 17 Zawada AM, Rogacev KS, Rotter B. , et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 2011; 118 (12) e50-e61
- 18 Chimen M, Yates CM, McGettrick HM. , et al. Monocyte subsets coregulate inflammatory responses by integrated signaling through TNF and IL-6 at the endothelial cell interface. J Immunol 2017; 198 (07) 2834-2843
- 19 Auffray C, Fogg D, Garfa M. , et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007; 317 (5838): 666-670
- 20 Cros J, Cagnard N, Woollard K. , et al. Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 2010; 33 (03) 375-386
- 21 Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009; 102 (05) 916-924
- 22 Rogacev KS, Cremers B, Zawada AM. , et al. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 2012; 60 (16) 1512-1520
- 23 Ghigliotti G, Barisione C, Garibaldi S. , et al. CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-associated biochemical and inflammatory biomarkers. Dis Markers 2013; 34 (02) 131-142
- 24 Rubio-Navarro A, Amaro Villalobos JM, Lindholt JS. , et al. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm. Int J Cardiol 2015; 201: 66-78
- 25 Pillay J, Ramakers BP, Kamp VM. , et al. Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia. J Leukoc Biol 2010; 88 (01) 211-220
- 26 Kamp VM, Pillay J, Lammers JWJ, Pickkers P, Ulfman LH, Koenderman L. Human suppressive neutrophils CD16bright/CD62Ldim exhibit decreased adhesion. J Leukoc Biol 2012; 92 (05) 1011-1020
- 27 Al-Barjas HS, Ariëns R, Grant P, Scott JA. Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology 2006; 57 (05) 607-614
- 28 Bailey MA, Griffin KJ, Sohrabi S. , et al. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm. J Vasc Surg 2013; 57 (06) 1512-1518
- 29 Parry DJ, Al-Barjas HS, Chappell L, Rashid ST, Ariëns RA, Scott DJ. Markers of inflammation in men with small abdominal aortic aneurysm. J Vasc Surg 2010; 52 (01) 145-151
- 30 Scott DJ, Prasad P, Philippou H. , et al. Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size. Arterioscler Thromb Vasc Biol 2011; 31 (12) 3004-3010
- 31 Sohrabi S, Wheatcroft S, Barth JH. , et al. Cardiovascular risk in patients with small and medium abdominal aortic aneurysms, and no history of cardiovascular disease. Br J Surg 2014; 101 (10) 1238-1243
- 32 Tjur T. Coefficients of determination in logistic regression models—a new proposal: the coefficient of discrimination. Am Stat 2009; 63: 366-372
- 33 Vardulaki KA, Walker NM, Day NE, Duffy SW, Ashton HA, Scott RA. Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 2000; 87 (02) 195-200
- 34 Piechota-Polanczyk A, Jozkowicz A, Nowak W. , et al. The abdominal aortic aneurysm and intraluminal thrombus: current concepts of development and treatment. Front Cardiovasc Med 2015; 2: 19
- 35 Dale MA, Ruhlman MK, Baxter BT. Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy. Arterioscler Thromb Vasc Biol 2015; 35 (08) 1746-1755
- 36 Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 2006; 80 (05) 1156-1164
- 37 Middleton RK, Lloyd GM, Bown MJ, Cooper NJ, London NJ, Sayers RD. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg 2007; 45 (03) 574-580
- 38 Jones GT, Phillips LV, Williams MJ, van Rij AM, Kabir TD. Two C-C family chemokines, eotaxin and RANTES, are novel independent plasma biomarkers for abdominal aortic aneurysm. J Am Heart Assoc 2016; 5 (05) 5
- 39 Mayr FB, Spiel AO, Leitner JM. , et al. Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinant monocyte chemoattractant protein (MCP-1, CCL-2) in vivo. Int J Immunopathol Pharmacol 2009; 22 (03) 615-625
- 40 Feng AL, Zhu JK, Sun JT. , et al. CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clin Exp Immunol 2011; 164 (01) 57-65
- 41 Yamanouchi D, Morgan S, Kato K, Lengfeld J, Zhang F, Liu B. Effects of caspase inhibitor on angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2010; 30 (04) 702-707
- 42 Wang Q, Ren J, Morgan S, Liu Z, Dou C, Liu B. Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm. PLoS One 2014; 9 (03) e92053
- 43 Pradhan-Palikhe P, Vikatmaa P, Lajunen T. , et al. Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm. Scand J Immunol 2010; 72 (02) 150-157
- 44 Odobasic D, Kitching AR, Holdsworth SR. Neutrophil-mediated regulation of innate and adaptive immunity: the role of myeloperoxidase. J Immunol Res 2016; 2016: 2349817
- 45 Wildgruber M, Aschenbrenner T, Wendorff H. , et al. The “Intermediate” CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans. Sci Rep 2016; 6: 39483
- 46 Choi M, Rolle S, Wellner M. , et al. Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 2003; 102 (06) 2259-2267